PCSK9-IN-10, CAS [[368434-98-4]]

Produktübersicht

• Artikelname: PCSK9-IN-10, CAS [[368434-98-4]]
• Artikelnummer: TGM-T72025
• Hersteller Artikelnummer: T72025
• Alternativnummer: TGM-T72025-1MLX10MM(INDMSO),TGM-T72025-2MG,TGM-T72025-5MG,TGM-T72025-10MG,TGM-T72025-25MG,TGM-T72025-50MG,TGM-T72025-100MG,TGM-T72025-200MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

PCSK9-IN-10, a potent and orally active inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), exhibits a half-maximal inhibitory concentration (IC50) of 6.4 µM. By enhancing the expression of Low-Density Lipoprotein Receptor (LDLR) protein and reducing PCSK9 expression, PCSK9-IN-10 effectively decreases atherosclerosis progression. This compound holds promise for hyperlipidemia research applications.

Produkteigenschaften

• Molekulargewicht: 373.41
• Reinheit: 99.06%
• CAS Nummer: [368434-98-4]
• Formel: C18H23N5O4
• Target-Kategorie: Serine/threonin kinase|||Others|||LDLR

Bilder

T72025